SPONSOR
Universität Münster
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2
Conditions studied: Critically IllAcute Kidney InjurySepsisGlioblastomaOrgan TransplantationVasoplegiaVasoplegic Shock
Universität Münster is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Critically Ill, Acute Kidney Injury, Sepsis, Glioblastoma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universität Münster
How many clinical trials has Universität Münster sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Universität Münster, of which 4 are actively recruiting participants. These trials cover conditions including Critically Ill, Acute Kidney Injury, Sepsis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universität Münster research focus on?
Universität Münster clinical trials span Critically Ill, Acute Kidney Injury, Sepsis, Glioblastoma, Organ Transplantation, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universität Münster clinical trial?
To participate in a Universität Münster trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universität Münster trials with current recruitment status updated daily.
Clinical Trials by Universität Münster
NCT05830669
Recruiting
Remote Ischemic Preconditioning in Septic Patients
Critically Ill
NCT05590689 Phase 1, Phase 2
Recruiting
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
Glioblastoma
NCT06652919
Recruiting
Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients
Organ Transplantation
NCT05833828
Recruiting
Differential Regulation of RAAS-axis in Patients Undergoing Cardiac Surgery
Vasoplegia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology